Actively Recruiting
A Series of Studies Based on a Prospective Birth Cohort of Infants With Allergy and Neurodevelopmental Disorders in China
Led by Qilu Hospital of Shandong University · Updated on 2024-03-25
6000
Participants Needed
1
Research Sites
156 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are studying a birth cohort of infants to understand how allergies might be linked to neurodevelopmental disorders such as autism spectrum disorder (ASD), attention deficit hyperactivity disorder (ADHD), and learning disabilities. The study aims to identify factors in early life that influence these neurodevelopmental outcomes using standard diagnostic criteria (DSM-5). This observational study is led by Qilu Hospital of Shandong University and focuses on children living in Jinan City and nearby areas in China. Infants in the study are divided into two groups based on allergy status: an allergic group and a control group without allergies. They will be followed for up to six years, with periodic collection of biological samples like blood, urine, and feces. Growth measurements such as height and weight, along with developmental assessments like the GESELL test, will be recorded during regular follow-ups. Participants will undergo evaluations to monitor for signs of ASD, ADHD, or learning disabilities over the study period. Researchers will gather data through questionnaires and clinical examinations at multiple time points from 2023 to 2029. This long-term follow-up helps assess how early-life allergies may affect neurodevelopment. The study provides ongoing monitoring but does not involve any treatment interventions.
CONDITIONS
Brief Title
A Prospective Birth Cohort of Infants With Allergy and Neurodevelopmental Disorders in China
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Positive results on an allergy questionnaire
- Living in Jinan City or surrounding areas in Shandong Province for convenient follow-up
You will not qualify if you...
- Clear diagnosis of brain developmental disorders
- Psychological diseases
- History of craniocerebral trauma or brain organic disease
- Major physical diseases
- Visual and auditory disorders
- Epilepsy
- Intellectual disabilities
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Up to 6 years
Participants are followed up for up to 6 years with collection of specimens (blood, urine, feces) and test data (height, weight, developmental assessments).
Periodic visits over 6 years
Trial Site Locations
Total: 1 location
1
Qilu Hospital of Shandong University
Jinan, Shandong, China
Actively Recruiting
Research Team
C
cao aihua, post-doctoral
Z
zhu mengna, postgraduate
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here